Covered recipient · General Payments record
VEENA REDDY
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2020–2024
$1,326.23
- Reported across 70 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $380.68 | 16 |
| Entertainment | $43.49 | 2 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | $71.81 | 3 |
| ABIOMED | $59.84 | 2 |
| Supernus Pharmaceuticals, Inc. | $57.30 | 1 |
| GlaxoSmithKline, LLC. | $47.10 | 2 |
| OPTOS, INC. | $43.49 | 2 |
| Lilly USA, LLC | $39.87 | 2 |
| Abbott Laboratories | $38.44 | 2 |
| ABBVIE INC. | $35.70 | 2 |
| Acerta Pharma LLC | $15.60 | 1 |
| Sumitomo Pharma America, Inc. | $15.02 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $23.85 | 02/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125244838 | CMS |
| Abbott Laboratories | $14.59 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125244842 | CMS |
| ABBVIE INC. | $13.08 | 09/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105930147 | CMS |
| ABBVIE INC. | $22.62 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105930149 | CMS |
| ABIOMED | $15.92 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142299955 | CMS |
| ABIOMED | $43.92 | 12/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1142300111 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.60 | 09/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104737627 | CMS |
| GlaxoSmithKline, LLC. | $32.71 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116051883 | CMS |
| GlaxoSmithKline, LLC. | $14.39 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116415419 | CMS |
| Lilly USA, LLC | $19.24 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135494290 | CMS |
| Lilly USA, LLC | $20.63 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135494292 | CMS |
| Optos, Inc. | $17.75 | 04/17/2024 | Entertainment | Undisputed | 01/23/2026 | 1141504928 | CMS |
| Optos, Inc. | $25.74 | 11/15/2024 | Entertainment | Undisputed | 01/23/2026 | 1141504930 | CMS |
| Phathom Pharmaceuticals, Inc. | $28.31 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151115051 | CMS |
| Phathom Pharmaceuticals, Inc. | $27.25 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151115053 | CMS |
| Phathom Pharmaceuticals, Inc. | $16.25 | 06/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151115055 | CMS |
| Sumitomo Pharma America, Inc. | $15.02 | 10/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148908564 | CMS |
| Supernus Pharmaceuticals, Inc. | $57.30 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147837074 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2020, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.